Cogent Biosciences, Inc. (COGT)
37.08
-0.38
(-1.01%)
USD |
NASDAQ |
Mar 06, 16:00
37.06
-0.02
(-0.05%)
After-Hours: 20:00
Cogent Biosciences SG&A Expense (TTM) : 63.58M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Merck & Co., Inc. | 10.73B |
| Sarepta Therapeutics, Inc. | 491.72M |
| BridgeBio Pharma, Inc. | 531.22M |
| Olema Pharmaceuticals, Inc. | 18.61M |
| Revolution Medicines, Inc. | 195.04M |